Moderna, Inc. financial metrics

Professional SEC-based dashboard for profitability, financial health, and growth with transparent scoring logic. Latest period: Q4 2025.

Symbol
MRNA on Nasdaq
Location
Cambridge, MA
Fiscal year end
31 December
Latest financial report
20 Feb 2026

Quick Takeaways

  • MRNA - Moderna, Inc. financial facts are built from SEC company filings data.
  • Latest metrics period on this page: Q4 2025.
  • Headline metric: Return On Equity -29%.

What Changed

  • Return On Equity YoY change: <span class="text-green-600">+0.34%</span>.
  • Most recent SEC facts end date: 13 Feb 2026.

Why This Matters

  • This gives a beginner-friendly first read before you inspect detailed formulas and metric tables.
  • Every metric card links to a deeper SEC-backed history page for verification.

Official SEC Source

Based on latest 10-Q/10-K

Facts and ratios are grounded in SEC company facts linked to the latest 10-Q/10-K cycle.

See Original Filing

Latest SEC snapshot (2026-02-13) highlights Return On Equity -28.9%, Return On Assets -14.5%, and Operating Margin -126.4%.

Financial Quality Score

Transparent 0-100 scoring model based on profitability, financial health, and growth factors.

39.0/100

Weak Confidence high

Return On Equity

-29%

Metric score 0.0/100

Return On Assets

-15%

Metric score 0.0/100

Financial Health

Current Ratio
3.29x
Quick Ratio
3.06x
Debt to Equity
0.15x

Strengths

Debt-to-equity and NetIncomeLoss YoY

Watchpoints

Return On Equity, Return On Assets, and Operating Margin

Key metrics snapshot

Return On Equity

-29%

YoY: +0.34%

Industry median: -47% (n=218)

View history

Return On Assets

-15%

YoY: -2.5%

Industry median: -44% (n=217)

View history

Operating Margin

-126%

YoY: +30%

Industry median: -263% (n=94)

View history

Current Ratio

3.29x

YoY: -10%

Industry median: 3.67x (n=218)

View history

Quick Ratio

3.06x

YoY: +35%

Industry median: 2.03x (n=83)

View history

Debt-to-equity

0.15x

YoY: -0.98%

Industry median: 0.31x (n=169)

View history

Revenues YoY

-40%

YoY:

Industry median: 11% (n=96)

View history

NetIncomeLoss YoY

21%

YoY:

Industry median: -12% (n=211)

View history

Profitability

Metric Latest value YoY change
Return On Equity -29% +0.34%
Return On Assets -15% -2.5%
Operating Margin -126% +30%

Financial Health

Metric Latest value YoY change
Current Ratio 3.29x -10%
Quick Ratio 3.06x +35%
Debt-to-equity 0.15x -0.98%

Growth

Metric Latest value YoY change
Revenues YoY -40%
NetIncomeLoss YoY 21%

Share Metrics

Metric Latest value YoY change
Entity Common Stock, Shares Outstanding 394,939,424 +2.4%
Common Stock, Shares, Outstanding 394,000,000 +2.1%
Common Stock, Value, Issued $0
Weighted Average Number of Shares Outstanding, Basic 389,000,000 +1.3%
Weighted Average Number of Shares Outstanding, Diluted 389,000,000 +1.3%

Additional Metrics

Metric Latest value YoY change
Revenue from Contract with Customer, Excluding Assessed Tax $1,944,000,000 -40%
Research and Development Expense $3,132,000,000 -31%
General and Administrative Expense $1,018,000,000 -13%
Costs and Expenses $5,018,000,000 -30%
Operating Income (Loss) $3,074,000,000 +22%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest $2,768,000,000 +23%
Income Tax Expense (Benefit) $54,000,000
Earnings Per Share, Basic -7.26 +22%
Earnings Per Share, Diluted -7.26 +22%
Cash and Cash Equivalents, at Carrying Value $2,595,000,000 +35%
Accounts Receivable, after Allowance for Credit Loss, Current $184,000,000 -49%
Inventory, Net $153,000,000 +31%
Other Assets, Current $45,000,000 -22%
Assets, Current $6,544,000,000 -19%
Deferred Income Tax Assets, Net $81,000,000 0%
Operating Lease, Right-of-Use Asset $719,000,000 -5.3%
Goodwill $52,000,000 0%
Other Assets, Noncurrent $605,000,000 +1.9%
Assets $12,338,000,000 -13%
Accounts Payable, Current $317,000,000 -22%
Employee-related Liabilities, Current $420,000,000 +35%
Accrued Liabilities, Current $1,386,000,000 -2.9%
Contract with Customer, Liability, Current $99,000,000 -35%
Liabilities, Current $1,987,000,000 -9.9%
Contract with Customer, Liability, Noncurrent $153,000,000 +164%
Deferred Income Tax Liabilities, Net $249,000,000 +7.8%
Operating Lease, Liability, Noncurrent $653,000,000 -2.7%
Other Liabilities, Noncurrent $285,000,000 +6.7%
Liabilities $3,688,000,000 +14%
Accumulated Other Comprehensive Income (Loss), Net of Tax $45,000,000
Retained Earnings (Accumulated Deficit) $7,223,000,000 -28%
Stockholders' Equity Attributable to Parent $8,650,000,000 -21%
Liabilities and Equity $12,338,000,000 -13%
Common Stock, Shares Authorized 1,600,000,000 0%
Common Stock, Shares, Issued 394,000,000 +2.1%
Common Stock, Par or Stated Value Per Share 0.0001 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $2,597,000,000 +35%
Deferred Tax Assets, Valuation Allowance $3,738,000,000 +21%
Deferred Tax Assets, Gross $4,014,000,000 +19%
Operating Lease, Liability $670,000,000 -2.2%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $2,767,000,000 +20%
Lessee, Operating Lease, Liability, to be Paid $1,066,000,000 -5.6%
Operating Lease, Liability, Current $17,000,000 +21%
Operating Lease, Weighted Average Discount Rate, Percent 0.076 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $396,000,000 -11%
Deferred Tax Assets, Operating Loss Carryforwards $1,156,000,000 +173%
Preferred Stock, Shares Issued 0
Preferred Stock, Shares Authorized 162,000,000 0%
Unrecognized Tax Benefits $241,000,000 +0.42%
Additional Paid in Capital $1,382,000,000 +60%
Preferred Stock, Shares Outstanding 0
Depreciation, Depletion and Amortization $211,000,000 +14%
Deferred Tax Assets, Net of Valuation Allowance $276,000,000 -0.36%
Share-based Payment Arrangement, Expense $483,000,000 +13%
Preferred Stock, Par or Stated Value Per Share 0.0001 0%

How we score

This score is transparent and deterministic. We weight profitability, financial health, and growth metrics, then renormalize weights when SEC data is missing.

Metric Weight V1 threshold
ROIC205% to 20%
ROE158% to 25%
ROA102% to 10%
Operating Margin55% to 25%
Current Ratio121.0x to 2.0x
Quick Ratio80.8x to 1.5x
Debt to Equity100.3x to 2.0x (lower is better)
Revenue YoY10-10% to +20%
Net Income YoY10-10% to +20%

How Calculated (standard_v1)

Metrics are computed with a market-consensus convention designed for cross-portal comparability.

  • TTM Operating Income / TTM Revenues
  • Current Assets / Current Liabilities (latest instant quarter)
  • (Current Assets - Inventory) / Current Liabilities; fallback: (Cash+Short-Term Investments + Accounts Receivable) / Current Liabilities
  • Total Debt / Stockholders Equity (latest instant quarter; shared unit; freshest series)
  • TTM Net Income / Average Equity (current quarter + same quarter previous year) / 2
  • TTM Net Income / Average Assets (current quarter + same quarter previous year) / 2
  • TTM NOPAT / Average Invested Capital, where NOPAT=Operating Income*(1-tax rate), Invested Capital=Equity+Total Debt-Cash & ST Investments
  • TTM Revenues YoY
  • TTM Net Income YoY